Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health and Consumer Healthcare, and Nutrition. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Its Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. On August 1, 2011, it completed the sale of its Capsugel business. In October 2011, it acquired Icagen, Inc. In December 2011, it acquired the consumer healthcare business of Ferrosan Holding A/S. In December 2011, it acquired Excaliard Pharmaceuticals, Inc. In November 2012, the Company acquired NextWave Pharmaceuticals, Inc.
|Headquarters||235 East 42nd Street|
NEW YORK, NY, United States 10017-5755
|Chairman of the Board, Chief Executive Officer||Ian Read|
|Chief Financial Officer, Executive Vice President - Business Operations||Frank D'Amelio|
|President - Worldwide Research and Development||Mikael Dolsten|
|Executive Vice President, Chief Compliance and Risk Officer||Douglas Lankler|
|Executive Vice President, General Counsel, Business Unit Lead - Consumer Healthcare||Amy Schulman|
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
|Shares Out.||7.1B||Book Value||$11.17|
|Annual Dividend Rate||$0.96||Price/Sales (TTM)||3.6|
|Ex-Div Date||5/8/13||P/Cash Flow (TTM)||10.8x|
|Pay Date||8/8/13||Operating Margin||23.55%|
*GAAP = prior to non-GAAP analyst adjusted earnings.